11:15 AM – 11:20 AM

Introductory Remarks

Robert J. DiDomenico, Pharm.D.
Program Chair

11:20 AM – 12:05 PM

Update on the Current Treatment of ADHF

Mitchell T. Saltzberg, M.D., FACC

12:05 PM – 12:50 PM

Therapeutic Challenges in ADHF: Clarity and Controversy

Mark A. Munger, Pharm.D.

12:50 PM – 1:35 PM

Using Critical Care Pathways and Pharmacoeconomics to Guide ADHF Treatment Decisions

Robert J. DiDomenico, Pharm.D.
Program Chair

1:35 PM – 1:45 PM

Questions & Answers